Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Drotrecogin alfa (activated) for severe sepsis: Could we consider a shorter treatment period in patients with a favorable course
Journal of Critical Care, 07/29/09
Ahishakiye D et al. – A simple model based on sequential organ failure assessment score and arterial pH can help identify patients with a rapid favorable course in whom a shorter duration of DAA treatment may be justified.
Related Articles
Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alfa (activated)
Journal of Thrombosis and Haemostasis, 10/27/09
Relevance Score: 65%
Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer
Journal of Clinical Oncology, 11/09/09
Relevance Score: 43%
Effect of agalsidase alfa replacement therapy on fabry disease—related hypertrophic cardiomyopathy: A 12- to 36-month, retrospective, blinded echocardiographic pooled analysis
Clinical Therapeutics, 10/29/09
Relevance Score: 43%
Pharmacotherapy of chronic hepatitis C virus infection ? the IDEAL trial: 2b or not 2b (= 2a), that is the question
Expert Opinion in Pharmacotherapy, 11/10/09
Relevance Score: 42%
Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09
Relevance Score: 42%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/03/09
Amlodipine/Valsartan/Hydrochlorothiazide: Fixed-Dose Combination in Hypertension
American Journal of Cardiovascular Drugs, 12/03/09
Rosiglitazone May Assist With Glycemic Control on the ICU
Journal of Intensive Care Medicine, 12/03/09
Today in Critical Care/Hospitalist...keeping you current
Receive free subspecialty "5-minute updates" via email
Rosiglitazone May Assist With Glycemic Control on the ICU
Journal of Intensive Care Medicine, 12/03/09
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
JAMA, 12/02/09
Evidence lost to treatment of critically-ill patients
Minerva Anestesiologica, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


